OBJECTIVES: We investigated whether oxidative stress and the arginine/nitric oxide pathway differ in control subjects and in adult patients who are candidates for the three most common cardiac surgical operations: coronary bypass surgery, aortic valve replacement for calcific non-rheumatic aortic stenosis or mitral valve repair for degenerative mitral insufficiency. METHODS: In this prospective observational study, we studied 165 consecutive patients undergoing surgery from January to June 2011 (coronary bypass surgery, n = 63; aortic valve replacement for calcific non-rheumatic aortic stenosis, n = 51; mitral valve repair for degenerative mitral insufficiency, n = 51). Thirty-three healthy subjects with cardiovascular risk factors similar to surgery patients were also studied (Controls). Oxidative stress (the ratio of reduced and oxidized glutathione and urinary isoprostane), antioxidants (alpha- and gamma tocopherol) and factors involved in nitric oxide synthesis (arginine, symmetric and asymmetric dimethylarginine) were measured before surgery. Analysis of variance general linear models and principal component analysis were used for statistical analysis. RESULTS: Surgical patients had increased levels of oxidative stress and decreased levels of antioxidants. Increased levels of nitric oxide inhibitor asymmetric dimethylarginine were detected in surgical candidates, suggesting arginine/nitric oxide pathway impairment. Concerning the differences among surgical procedures, higher oxidative stress and a major imbalance of the ratio between substrate and inhibitors of nitric oxide synthesis were evidenced in patients who were candidates for mitral valve repair with respect to coronary bypass surgery patients and patients with calcific non-rheumatic aortic stenosis. CONCLUSIONS: Patients undergoing cardiac surgery have increased oxidative stress and a trend towards an impaired arginine/nitric oxide pathway with respect to Controls. Patients affected by mitral valve regurgitation show more pronounced perturbations in these pathways. The clinical implications of these findings need to be investigated.
OBJECTIVES: We investigated whether oxidative stress and the arginine/nitric oxide pathway differ in control subjects and in adult patients who are candidates for the three most common cardiac surgical operations: coronary bypass surgery, aortic valve replacement for calcific non-rheumatic aortic stenosis or mitral valve repair for degenerative mitral insufficiency. METHODS: In this prospective observational study, we studied 165 consecutive patients undergoing surgery from January to June 2011 (coronary bypass surgery, n = 63; aortic valve replacement for calcific non-rheumatic aortic stenosis, n = 51; mitral valve repair for degenerative mitral insufficiency, n = 51). Thirty-three healthy subjects with cardiovascular risk factors similar to surgery patients were also studied (Controls). Oxidative stress (the ratio of reduced and oxidized glutathione and urinary isoprostane), antioxidants (alpha- and gamma tocopherol) and factors involved in nitric oxide synthesis (arginine, symmetric and asymmetric dimethylarginine) were measured before surgery. Analysis of variance general linear models and principal component analysis were used for statistical analysis. RESULTS: Surgical patients had increased levels of oxidative stress and decreased levels of antioxidants. Increased levels of nitric oxide inhibitor asymmetric dimethylarginine were detected in surgical candidates, suggesting arginine/nitric oxide pathway impairment. Concerning the differences among surgical procedures, higher oxidative stress and a major imbalance of the ratio between substrate and inhibitors of nitric oxide synthesis were evidenced in patients who were candidates for mitral valve repair with respect to coronary bypass surgery patients and patients with calcific non-rheumatic aortic stenosis. CONCLUSIONS:Patients undergoing cardiac surgery have increased oxidative stress and a trend towards an impaired arginine/nitric oxide pathway with respect to Controls. Patients affected by mitral valve regurgitation show more pronounced perturbations in these pathways. The clinical implications of these findings need to be investigated.
Authors: V Cavalca; G Cighetti; F Bamonti; A Loaldi; L Bortone; C Novembrino; M De Franceschi; R Belardinelli; M D Guazzi Journal: Clin Chem Date: 2001-05 Impact factor: 8.327
Authors: José P Werba; Viviana Cavalca; Fabrizio Veglia; Paola Massironi; Michela De Franceschi; Lorenzo Zingaro; Elena Tremoli Journal: Atherosclerosis Date: 2006-07-24 Impact factor: 5.162
Authors: Marcel Liberman; Estêvão Bassi; Marina Kamla Martinatti; Fábio Cerqueira Lario; João Wosniak; Pablo M A Pomerantzeff; Francisco R M Laurindo Journal: Arterioscler Thromb Vasc Biol Date: 2007-12-27 Impact factor: 8.311
Authors: Julio J Ochoa; Maria J Vilchez; José Mataix; Susana Ibáñez-Quiles; Miguel A Palacios; Antonio Muñoz-Hoyos Journal: J Surg Res Date: 2003-05-15 Impact factor: 2.192
Authors: Jordan D Miller; Yi Chu; Robert M Brooks; Wayne E Richenbacher; Ricardo Peña-Silva; Donald D Heistad Journal: J Am Coll Cardiol Date: 2008-09-02 Impact factor: 24.094
Authors: Danielle J Huk; Blair F Austin; Tori E Horne; Robert B Hinton; William C Ray; Donald D Heistad; Joy Lincoln Journal: Arterioscler Thromb Vasc Biol Date: 2015-12-03 Impact factor: 8.311
Authors: Linda Turnu; Alessandro Di Minno; Benedetta Porro; Isabella Squellerio; Alice Bonomi; Chiara Maria Manega; José Pablo Werba; Alessandro Parolari; Elena Tremoli; Viviana Cavalca Journal: Oxid Med Cell Longev Date: 2017-06-04 Impact factor: 6.543
Authors: Kelly Casós; Gemma Ferrer-Curriu; Paula Soler-Ferrer; María L Pérez; Eduard Permanyer; Arnau Blasco-Lucas; Juan Manuel Gracia-Baena; Miguel A Castro; Carlos Sureda; Jordi Barquinero; Manuel Galiñanes Journal: PLoS One Date: 2017-04-05 Impact factor: 3.240